Profilaxis extendida de enfermedad venosa tromboembólica en cirugía oncológica abdominopelviana
Bilbao, María Soledad; Vaccaro, Carlos Alberto.
Rev. Hosp. Ital. B. Aires (2004)
; 37(1): 26-27, mar. 2017.
Artículo en Español | LILACS | ID: biblio-966986
Documentos relacionados
Seek and ye shall find: The utility of perioperative VTE screening in high-risk oncologic patients undergoing abdominopelvic surgery.
Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.
Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis.
Direct oral anticoagulants (DOACs) versus low-molecular-weight heparin (LMWH) for extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: a systematic review and meta-analysis.
Extended duration chemoprophylaxis for venous thromboembolism following abdominopelvic oncologic surgery.
The Perioperative Management of Antithrombotic Therapies Using Enoxaparin.
[Massive panniculectomy and bilateral subtotal mastectomy in a case of calciphylaxis: A case report and up date].
Form of presentation, natural history and course of postoperative venous thromboembolism in patients operated on for pelvic and abdominal cancer. Analysis of the RIETE registry.
Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery.
Venous thromboembolism prophylaxis following colorectal surgery: a survey of American Society of Colon and Rectal Surgery (ASCRS) member surgeons.